부광약품
ABOUT BUKWANG
Company Introduction
Vision & Mission
History
Manufacturing Facilities
Subsidiaries & Affiliates
Contact us
R&D
R&D Facilities
Pipeline
Latuda
JM-010
CP-012
Open Innovation
NEWS
IR
Financial Information
IR Reports
ANNUAL REPORT
PRODUCTS
Product Search
ETC
OTC
Health Functional Food
Personal Care Products
HOME
CONTACT US
KR
KR
EN
ABOUT BUKWANG
Company Introduction
Vision & Mission
History
Manufacturing Facilities
Subsidiaries & Affiliates
Contact us
R&D
R&D Facilities
Pipeline
Latuda
JM-010
CP-012
Open Innovation
JaguAhr
Protekt
NEWS
News
IR
Financial Information
IR Reports
ANNUAL REPORT
PRODUCTS
Product Search
ETC
OTC
Health Functional Food
Personal Care Products
NEWS
HOME
NEWS
NEWS
NEWS
ALL
Company news
Product news
R&D news
Product news | Bukwang Pharm. launches GingQ Premium – nutritional suppleme..
Bukwang Pharmaceutical Co., Ltd. announced launch of “GingQ Premium” which can h..
2016.05.17
Product news | Bukwang Pharm. signs export agreement for own incrementally ..
Bukwang Pharmaceutical Co., Ltd. announced on March 3rd that they signed an expo..
2016.03.09
Company news | Bukwang Pharm. receives orphan drug designation for apatinib..
Bukwang Pharmaceutical Co., Ltd. announced receipt of orphan drug designation fo..
2016.02.15
Product news | Bukwang signs exclusive marketing agreement with Eisai on S..
Bukwang Pharmaceutical Co., Ltd. announced that Bukwang and Eisai Korea Inc. sig..
2016.01.18
Company news | Bukwang Pharm leading the market for generics of Baraclude
Since patent expiry of Baraclude on October 10th, 62 generics have been launched..
2015.12.17
R&D news | Bukwang completes Phase IIa clinical trial for novel anti-di..
Bukwang Pharmaceutical Co., Ltd. announced completion of Phase IIa of “MLR-1023”..
2015.12.15
11
12
13
14
15